Medical News

RSS

Medicaid expansion could hit struggling state budgets

"The government programs that provide health care to the poor would expand to cover nearly one in five Americans under health insurance legislation pending in Congress, putting pressure on federal and state budgets," USA Today reports.

19 Oct 2009

Amarin selects Medpace as CRO for its Phase 3 AMR101 MARINE clinical study

Amarin Corporation plc today announced that it has executed an agreement with Medpace, Inc. (‘Medpace’), a leading Contract Research Organization (CRO) with expertise in conducting clinical trials in cardiovascular and metabolic disease, to engage their services in the execution of its Phase 3 clinical trials with AMR101 in patients with very high triglyceride levels (the AMR101 MARINE Study) and mixed dyslipidemia.

19 Oct 2009

AccuVein signs five-year agreement with the Ferrer Group

AccuVein LLC today announced a five-year agreement with the Ferrer Group, a leading international pharmaceutical and medical devices distribution company, providing the AccuVein AV300, the world's first hand-held, non-contact vein illumination device, to customers in Greece, Spain and Portugal.

19 Oct 2009

Apollo Medical Holdings completes sale of convertible notes and warrants of value $1.25M

Apollo Medical Holdings, Inc., a leading provider of management services to medical groups that provide comprehensive hospital-based medical services, today announced that it has completed the sale of convertible notes and warrants through a private placement offering.

19 Oct 2009

Is 'model health system' Geisinger replicable elsewhere?

Geisinger Health System, in central Pennsylvania, has been widely hailed as a model for health reform by leading Democrats including President Obama, the Philadelphia Inquirer reports. But, its success may hinge on "a rare combination of factors" including "a relative lack of competition, its stable patient base, and the fact that its 800 doctors are on salary," as well as an in-house pharmacy and insurance plan that covers one-third of its patients.

19 Oct 2009

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.

19 Oct 2009

Vangent announces launch of the Health Information Exchange Open Source software tool

Vangent, Inc., a leading global provider of information management and strategic business process outsourcing solutions, announced today that it will provide an open source software tool known as Health Information Exchange Open Source (HIEOS™) making possible secure exchange of health information from multiple and disparate system and data sources.

19 Oct 2009

Health reform bills may not protect consumers from treatment denials

"Despite growing frustration with the way health insurers deny medical treatments, major healthcare bills pending in Congress would give patients little new power to challenge those sometimes life-and-death decisions," The Los Angeles Times reports.

19 Oct 2009

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis (RA) receiving SIMPONI(TM) (golimumab) every four weeks achieved sustained improvements in signs and symptoms and physical function response through one year. These new data were presented today at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting.

19 Oct 2009

Insurers, other health businesses examine effect of reform bills

Health care industry CEOs are analyzing their wins and losses in the bills being considered in Congress.

19 Oct 2009

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for FORTESTA(TM) (testosterone) 2% Gel for men diagnosed with low testosterone (Low T), also known as hypogonadism.

19 Oct 2009

eHealth launches new website to help consumers learn about Medicare health plan options

Today, eHealth, Inc., parent company of eHealthInsurance, the leading online source of health insurance for individuals, families, and small businesses, announced the launch of a new online service to help consumers learn about, and get access to, quality Medicare health plan options.

19 Oct 2009

CSC's HealthSpace Advisor selected by GHHS to optimize revenue generation

CSC today announced that the Georgia Hospital Health Services (GHHS), a subsidiary of the Georgia Hospital Association (GHA), has selected CSC's HealthSpace Advisor, a Web-based benchmarking tool introduced earlier this year, to help member hospitals analyze how effectively they use space in key revenue generating areas.

19 Oct 2009

Bederra Corporation to acquire Texas Mobile Health

Bederra Corporation, a Houston, Texas based diversified medical services provider, announced that the company has signed a Letter of Intent to acquire Texas Mobile Health, Inc.

19 Oct 2009

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

A hospital that is using RapidArc radiotherapy to treat cancers of the head & neck and cervix is announcing it will be expanding its use for treatment of other cancers. Yashoda Cancer Institute in Hyderabad has found it can deliver image-guided, intensity modulated radiotherapy (IMRT) faster and more precisely using the RapidArc technology from Varian Medical Systems.

19 Oct 2009

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Applications (BLA) for Prolia(TM) (denosumab) in the treatment and prevention of postmenopausal osteoporosis.

19 Oct 2009

Positive results from Trubion Pharmaceuticals' Phase 2B study of TRU-015 for rheumatoid arthritis

Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.

19 Oct 2009

Amarin raises $70 million through private placement

Amarin Corporation plc today announced it has closed its $70 million private placement. The transaction was led by existing investor, Fountain Healthcare Partners, on behalf of funds affiliated with other existing investors Sofinnova Ventures, Orbimed Advisors and Longitude Capital. The new investor group was led by funds affiliated with Abingworth LLP and included APG Asset Management, Great Point Partners, Tavistock Life Sciences Company and RA Capital. Cowen and Company, LLC acted as the exclusive placement agent for the transaction.

19 Oct 2009

Clearcount Medical Solutions raises $3.4 million

ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today the close of its $3.4M Series B financing round. The company plans to use the funds to drive sales and product development of its RFID-based solutions designed to prevent retained surgical sponges.

19 Oct 2009

PLC Systems' RenalGuard to be utilized in a live case transmission at the GISE 2009 conference

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that its RenalGuard System(TM) will be utilized as part of a live case transmission from the Clinica Mediterranea, Naples, Italy, to the 30th Congresso Nazionale della Societa' Italiana di Cardiologia Invasiva (GISE) during the conference.

19 Oct 2009

Medical News

Medicaid expansion could hit struggling state budgets

Amarin selects Medpace as CRO for its Phase 3 AMR101 MARINE clinical study

AccuVein signs five-year agreement with the Ferrer Group

Apollo Medical Holdings completes sale of convertible notes and warrants of value $1.25M

Is 'model health system' Geisinger replicable elsewhere?

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Vangent announces launch of the Health Information Exchange Open Source software tool

Health reform bills may not protect consumers from treatment denials

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

Insurers, other health businesses examine effect of reform bills

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

eHealth launches new website to help consumers learn about Medicare health plan options

CSC's HealthSpace Advisor selected by GHHS to optimize revenue generation

Bederra Corporation to acquire Texas Mobile Health

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

Positive results from Trubion Pharmaceuticals' Phase 2B study of TRU-015 for rheumatoid arthritis

Amarin raises $70 million through private placement

Clearcount Medical Solutions raises $3.4 million

PLC Systems' RenalGuard to be utilized in a live case transmission at the GISE 2009 conference

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News